Evidence map›Paper›PMID 41847278›Full record

ArticleNeuro-ophthalmology (Aeolus Press)2026

A Case Report of Late-Onset Leber's Hereditary Optic Neuropathy Diagnosed Following Vision Loss After Cataract Surgery.

Hiroki Kawano, Masanori Nakazawa, Koji Kawano, Hiroto Terasaki, Taiji Sakamoto

Abstract readCase Reports
In one paragraph

Article in Neuro-ophthalmology (Aeolus Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroki KawanoKawano Eye Clinic, Satsumasendai, Kagoshima, Japan.
Masanori NakazawaDepartment of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Koji KawanoKawano Eye Clinic, Satsumasendai, Kagoshima, Japan.
Hiroto TerasakiDepartment of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Taiji SakamotoDepartment of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leber's Hereditary Optic Neuropathy (LHON) is a rare mitochondrial disorder characterized by acute to subacute vision loss, predominantly affecting young males. We report a case of a 65-year-old male diagnosed with late-onset LHON after experiencing significant vision decline following cataract surgery. The patient initially presented with decreased vision in the left eye. His best corrected visual acuity (BCVA) was 20/16 in the right eye and 20/600 in the left eye, with normal intraocular pressure. Thinning of the ganglion cell complex (GCC) and a central scotoma were observed in the left eye. As head MRI showed no abnormalities, some form of retinal vasculopathy was suspected. Two months later, he returned complaining of increased glare and visual impairment in the right eye. Since no changes except for cataracts had been detected, cataract surgery was performed on the right eye three and a half months after the initial visit, but the BCVA dropped to 20/63. At this point, thinning of the GCC in the papillomacular bundle area and a central scotoma in the right eye were also observed. Genetic testing confirmed the m.11778 G>A mutation, leading to a diagnosis of LHON. The impact of intraocular surgery on the progression of LHON remains unclear; however, it may negatively influence the disease course.

Indexed as

cataract surgerylate-onsetLeber’s hereditary optic neuropathym.11778G>A mutationvision loss

Identifiers

PMID41847278
PMCPMC12990941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.